NasdaqCM - Nasdaq Real Time Price USD

Astrana Health, Inc. (ASTH)

Compare
33.36
+2.02
+(6.45%)
At close: January 16 at 4:00:00 PM EST
33.61
+0.25
+(0.75%)
After hours: January 16 at 5:48:01 PM EST
Loading Chart for ASTH
DELL
  • Previous Close 31.34
  • Open 31.16
  • Bid 33.33 x 300
  • Ask 39.79 x 200
  • Day's Range 30.90 - 33.41
  • 52 Week Range 29.08 - 63.20
  • Volume 329,218
  • Avg. Volume 312,718
  • Market Cap (intraday) 1.523B
  • Beta (5Y Monthly) 1.24
  • PE Ratio (TTM) 25.66
  • EPS (TTM) 1.30
  • Earnings Date Feb 25, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 63.60

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

www.astranahealth.com

1,800

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ASTH

View More

Performance Overview: ASTH

Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ASTH
4.32%
S&P 500
0.51%

1-Year Return

ASTH
9.03%
S&P 500
24.11%

3-Year Return

ASTH
44.72%
S&P 500
27.33%

5-Year Return

ASTH
82.79%
S&P 500
80.51%

Compare To: ASTH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASTH

View More

Valuation Measures

Annual
As of 1/16/2025
  • Market Cap

    1.52B

  • Enterprise Value

    1.65B

  • Trailing P/E

    25.66

  • Forward P/E

    20.20

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.92

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    0.96

  • Enterprise Value/EBITDA

    11.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.63%

  • Return on Assets (ttm)

    4.49%

  • Return on Equity (ttm)

    10.26%

  • Revenue (ttm)

    1.72B

  • Net Income Avi to Common (ttm)

    62.46M

  • Diluted EPS (ttm)

    1.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    350.35M

  • Total Debt/Equity (mrq)

    93.87%

  • Levered Free Cash Flow (ttm)

    124.77M

Research Analysis: ASTH

View More

Company Insights: ASTH

Research Reports: ASTH

View More

People Also Watch